Preclinical PK/PD model for the combinatorial use of dexamethasone and sulpiride in the treatment of breast cancer

Previous studies show that dopamine D(2)-like receptor (D2DR) antagonist sulpiride (SUL) enhances the antitumor efficacy of dexamethasone (DEX) in drug-resistant breast cancer involving cancer stem-like cells (CSCs). In this study, we investigated the pharmacokinetic (PK) properties of SUL in nude m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Qing-yu, Li, Jian, Chen, Rong, Yao, Ye, Xue, Jun-sheng, Chen, Wen-jun, Lu, Wei, Zhou, Tian-yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470835/
https://www.ncbi.nlm.nih.gov/pubmed/31165782
http://dx.doi.org/10.1038/s41401-019-0251-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470835/
https://www.ncbi.nlm.nih.gov/pubmed/31165782
http://dx.doi.org/10.1038/s41401-019-0251-7

Ejemplares similares